Abdominal pain and hematochezia could be crucial red flags for early-onset colorectal cancer

FHS
May 29, 2024
3:57 am

The study identifies key symptoms like abdominal pain and hematochezia as significant indicators of early-onset colorectal cancer and stresses the importance of early diagnosis to improve survival rates.

Data Insights – Pharmaceutical Technology

By Company Name No Filter Selected Bristol-Myers Squibb (342) Novartis (237) Merck (187) AstraZeneca (181) Pfizer (177) F. Hoffmann-La Roche (164) AbbVie (148) Eli Lilly

February 16, 2024

Causal variant-targeted ribonucleic acid treatment for congenital melanocytic nevi

A genetic treatment targeting the causal NRAS c.181C>A mutation in congenital melanocytic naevus.

June 19, 2024

Blood test identifies specific pathologies in frontotemporal dementia, ALS, and PSP

In a study with 991 adults, scientists at DZNE show that the most common forms of frontotemporal dementia (FTD) as well as the neurological diseases

June 18, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.